Liquid biopsy and radiomics for liver cancer surveillance
Liquid biopsy and radiomics for liver cancer surveillance
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases
Enrolling: Male and Female Patients
Study Length: 3 Months
IRB Number: AAAV2053
Contact: Transplant Clinical Research Center: 212-305-3839 / tcrcstudyreferral@cumc.columbia.edu
Additional Study Information: This study aims to use new technology involving molecular and imaging tests to help detect liver cancer early in patients. Participants enrolled will participate in it for approximately 5 years. Participation will last approximately 3 months. If you have any questions regarding this study, please contact the Transplant Clinical Research Center (TCRC).
Investigator
Elizabeth Verna, MD
Do You Qualify?
Are you 18 years or older? Yes No
Do you have cirrhosis? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Transplant Clinical Research Center
tcrcstudyreferral@cumc.columbia.edu
212-305-3839
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE